Eton Pharmaceuticals, Inc. (ETON)
50.00
-0.02
(-0.04%)
USD |
NASDAQ |
Oct 23, 16:00
50.03
+0.03
(+0.06%)
After-Hours: 20:00
Eton Pharmaceuticals Market Cap : 1.414B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.414B |
| October 22, 2026 | 1.415B |
| October 21, 2026 | 1.395B |
| October 20, 2026 | 1.420B |
| October 19, 2026 | 1.392B |
| October 16, 2026 | 1.423B |
| October 15, 2026 | 1.452B |
| October 14, 2026 | 1.496B |
| October 13, 2026 | 1.509B |
| October 12, 2026 | 1.563B |
| October 09, 2026 | 1.562B |
| October 08, 2026 | 1.549B |
| October 07, 2026 | 1.553B |
| October 06, 2026 | 1.549B |
| October 05, 2026 | 1.573B |
| October 02, 2026 | 1.566B |
| October 01, 2026 | 1.471B |
| September 30, 2026 | 1.457B |
| September 29, 2026 | 1.674B |
| September 28, 2026 | 1.674B |
| September 25, 2026 | 1.632B |
| September 24, 2026 | 1.683B |
| September 23, 2026 | 1.573B |
| September 22, 2026 | 1.615B |
| September 21, 2026 | 1.565B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.570B |
| September 17, 2026 | 1.615B |
| September 16, 2026 | 1.594B |
| September 15, 2026 | 1.554B |
| September 14, 2026 | 1.630B |
| September 11, 2026 | 1.615B |
| September 10, 2026 | 1.637B |
| September 09, 2026 | 1.664B |
| September 08, 2026 | 1.679B |
| September 04, 2026 | 1.654B |
| September 03, 2026 | 1.695B |
| September 02, 2026 | 1.753B |
| September 01, 2026 | 1.710B |
| August 31, 2026 | 1.710B |
| August 28, 2026 | 1.691B |
| August 27, 2026 | 1.773B |
| August 26, 2026 | 1.772B |
| August 25, 2026 | 1.784B |
| August 24, 2026 | 1.823B |
| August 21, 2026 | 1.796B |
| August 20, 2026 | 1.695B |
| August 19, 2026 | 1.739B |
| August 18, 2026 | 1.794B |
| August 17, 2026 | 1.746B |
| August 14, 2026 | 1.665B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aquestive Therapeutics, Inc. | 502.05M |
| Pfizer Inc. | 171.14B |
| Elite Pharmaceuticals, Inc. | 269.07M |
| Daré Bioscience, Inc. | 9.798M |
| Liquidia Corp. | 3.800B |
Market Cap Related Metrics
| PE Ratio | 132.17 |
| PS Ratio | 14.50 |
| Price to Book Value | 30.36 |
| Price | 50.00 |
| Earnings Yield | 0.76% |
| Operating PE Ratio | 92.75 |
| Normalized PE Ratio | 130.45 |